Fe2O3-based nanozyme synergistic with oseltamivir for broad-spectrum inhibition of influenza A virus
International Immunopharmacology · 2026-07 · 181 · 116753
DOI: 10.1016/j.intimp.2026.116753 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-07. Verfasst von Yongkang Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology, Changchun University of Science and Technology, Changchun 130022, China; International Research Centre for Nan…. Hauptthemen laut MEDLINE: Oseltamivir, Antiviral Agents, Ferric Compounds, Orthomyxoviridae Infections. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Jilin Provincial Science and Technology Department.
Abstract (Originalsprache)
Influenza A virus infection is responsible for seasonal epidemics worldwide, which have a significant impact on public health and economic development. The therapeutic efficacy of the widely used antiviral drug oseltamivir (OTV) is often compromised by the emergence of drug resistance and adverse drug reactions in the body. The advantageous properties of γ-Fe2O3 nanoparticles, which include abundant surface hydroxyl groups, excellent biocompatibility, and nanoenzymatic activity, make them promising candidates for use as drug delivery platforms. In this study, γ-Fe2O3 was conjugated to OTV via Fe-O-P coordination bonding to construct a γ-Fe2O3-OTV nanodrug, with the aim of enhancing antiviral efficacy through combination therapy, reducing the required dose of OTV, and thereby potentially delaying the emergence of drug resistance. γ-Fe2O3-OTV exhibited significant inhibitory activity against influenza virus infection in both in vitro and in vivo models. γ-Fe2O3-OTV directly disrupts the viral envelope structure to inactivate the virus and suppress neuraminidase activity, inhibiting the release of viral progeny. In addition, γ-Fe2O3-OTV demonstrated effective scavenging of intracellular reactive oxygen species, thereby alleviating oxidative stress-induced inflammation and suppressing the cytokine. Significantly, γ-Fe2O3-OTV is a broad-spectrum inhibitor against different subtypes of influenza A viruses. This study presents a novel strategy for the application of nanomaterials in antiviral therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science and Technology, Changchun University of Science and Technology, Changchun 130022, China; International Research Centre for Nano Handling and Manufacturing of China, Changchun University of Science…
- Department of Radiology, China-Japan Union Hospital of Jilin University, Changchun 130021, Jilin, China.
- School of Life Science and Technology, Changchun University of Science and Technology, Changchun 130022, China.
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, State Key Laboratory of Pathogen and Biosecurity, Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun 130122…
- International Research Centre for Nano Handling and Manufacturing of China, Changchun University of Science and Technology, Changchun 130022, China.
- Department of Radiology, China-Japan Union Hospital of Jilin University, Changchun 130021, Jilin, China. Electronic address: zhangbt@jlu.edu.cn.
Förderung
- Jilin Provincial Science and Technology Department
Zitieren
APA
Li, Y., Jiang, Y., Zhang, Y., Sun, Y., Zhang, C., Wang, Y., Li, Y., Li, N., Wang, Z., Zhang, B., Sun, W., & He, X. (2026). Fe2O3-based nanozyme synergistic with oseltamivir for broad-spectrum inhibition of influenza A virus. International Immunopharmacology, 181, 116753. https://doi.org/10.1016/j.intimp.2026.116753
Vancouver
Li Y, Jiang Y, Zhang Y, Sun Y, Zhang C, Wang Y, et al. Fe2O3-based nanozyme synergistic with oseltamivir for broad-spectrum inhibition of influenza A virus. International Immunopharmacology. 2026;181:116753. doi:10.1016/j.intimp.2026.116753
BibTeX
@article{Li2026,
author = {Li, Yongkang and Jiang, Yuqing and Zhang, Yun and Sun, Yu and Zhang, Chong and Wang, Yexing and Li, Yuanguo and Li, Nan and Wang, Zuobin and Zhang, Butian and Sun, Weiyang and He, Xiuxia},
title = {Fe2O3-based nanozyme synergistic with oseltamivir for broad-spectrum inhibition of influenza A virus},
journal = {International Immunopharmacology},
year = {2026},
volume = {181},
pages = {116753},
doi = {10.1016/j.intimp.2026.116753}
}
EUVIMED